TREATMENT OF POSTPRANDIAL HYPERGLYCEMIA BY GASTRIC ELECTRICAL STIMULATION

• US 20120259389A1
• Filed: 04/12/2012
• Published: 10/11/2012
• Est. Priority Date: 09/21/2009
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Starkebaum, Warren, Burnes, John E., Maude-Griffin, Roland C.
• Application Number:
  US13/445,718
• Publication Number:
  US 20120259389A1
• Time in Patent Office: Days
• US Class Current: 607/62
• CPC Class Codes: A61B 5/0006 ECG or EEG signals
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/36171 Frequency
• CPC Class Codes: A61N 1/36175 Pulse width or duty cycle

Abstract

In some examples, the disclosure relates to a systems, devices, and techniques for delivering electrical stimulation therapy to a patient. In some example, the disclosure relates to systems and methods of treating hyperglycemia in a patient including delivering gastric electrical stimulation (GES) to the patient. Devices, systems and methods according to the disclosure may comprise an implantable stimulator, a blood glucose monitor and/or a food intake sensor. In some examples, a blood glucose level and/or food intake of a patient is detected and GES is delivered to the patient in response to the detection.

Claims

1. A method of treating hyperglycemia in a patient comprising:

measuring a blood glucose level of the patient;

determining whether the blood glucose level exceeds a predetermined threshold and if the blood glucose level exceeds the predetermined threshold,

delivering gastric electrical stimulation (GES) to a gastrointestinal tract (GI) of the patient.

2. The method of claim 1 wherein following the step of delivering GES, a gastric emptying of a stomach of the patient is delayed.

3. The method of claim 1 wherein measuring the blood glucose level of the patient further comprises periodically monitoring the blood glucose level of the patient.

4. The method of claim 1 wherein measuring the blood glucose level of the patient further comprises continuously monitoring the blood glucose level of the patient.

5. The method of claim 1 wherein delivering GES comprises placing at least two electrodes in a distal gastric antrum of the patient and stimulating the GI tract of the patient via the at least two electrodes.

6. The method of claim 1 wherein delivering GES comprises turning on an implantable stimulator.

7. The method of claim 6 wherein the implantable stimulator is configured to turn off if the measured blood glucose level is below the predetermined threshold.

8. The method of claim 1 wherein the predetermined threshold comprises approximately 140 mg/dL.

9. The method of claim 1 wherein the predetermined threshold comprises approximately 180 mg/dL.

10. The method of claim 1 wherein delivering GES further comprises delivering an electrical signal comprising an alternating monophasic waveform.

11. The method of claim 1 wherein delivering GES further comprises delivering a series of pulses with alternating pulse polarities to the (GI) tract of a patient, wherein the series of pulses includes at least a first pulse of a first polarity, a second pulse of a second polarity, and a third pulse of the first polarity, wherein the first, second and third pulses are delivered in direct succession, in that order, and wherein the first and second pulses are separated by a first time delay and the second and third pulses are separated by a second time delay.

12. The method of claim 11 wherein each of the series of pulses has a pulse width between approximately 0.025 milliseconds and approximately 500 milliseconds.

13. The method of claim 12 wherein the series of pulses are delivered at a pulse frequency between approximately 0.05 Hz and approximately 40 Hz.

14. The method of claim 13 wherein each of the series of pulses are delivered with a controlled current, and each of the series of pulses has an amplitude greater than zero and not less than approximately 25 milliamps.

15. A method of treating postprandial hyperglycemia of a patient comprising:

detecting the onset of consumption of food by the patient;

delivering gastric electrical stimulation (GES) to the patient in response to the detection;

wherein detecting the onset of consumption of food comprises detecting an event from the group consisting of;

contractile activity of the stomach, a change in the time of day, a change in a volume of the stomach, and a change in an electrical impedance between at least two electrodes located adjacent the stomach.

16. The method of claim 15 wherein delivering gastric electrical stimulation to the patient further comprises delivering GES via an implantable stimulator.

17. The method of claim 16 wherein the stimulator further comprises a pre-programmed schedule stored in a memory of the stimulator wherein the pre-programmed schedule defines one or more active time periods during which the stimulator is active and further wherein each of the one or more active time periods correspond to one or more meal times of the patient.

18. The method of claim 15 wherein delivering GES to the patient comprises delivering an electrical signal comprising an alternating monophasic waveform

19. The method of claim 18 wherein the electrical signal further comprises a series of pulses wherein each of the series of pulses comprises a pulse width of approximately 5 milliseconds;

wherein the series of pulses are delivered at a pulse frequency of approximately 40 Hz; and

each of the series of pulses comprises an amplitude of approximately 25 milliamps.

20. A method of treating postprandial hyperglycemia of a patient comprising:

measuring a stomach content of the patient comprising detecting the presence of food in the stomach of the patient;

delivering gastric electrical stimulation (GES) to the patient in response to the detection; and

turning on a stimulation timer.

21. The method of claim 20 further comprising comparing the measured stomach content to a predetermined threshold content value and if the measured content exceeds the threshold content value, incrementing the timer.

22. The method of claim 21 further comprising measuring the blood glucose level of the patient prior to the step of delivering GES.

23. A method of managing a blood glucose level of a patient comprising:

delivering gastric electrical stimulation (GES) to a gastrointestinal tract (GI) of the patient;

wherein the GES comprises a signal comprising an alternating monophasic waveform.

24. A system for managing a blood glucose level of a patient comprising:

a blood glucose monitor configured to measure the blood glucose level;

an implantable stimulator configured to deliver gastric electrical stimulation (GES) to a gastrointestinal tract (GI) of the patient;

wherein the implantable stimulator is configured to generate and deliver the GES when the blood glucose level exceeds a predetermined threshold.

25. The system of claim 24 wherein the blood glucose monitor is configured to communicate the blood glucose level to the implantable stimulator via one of wireless telemetry and an electrical lead assembly.

26. The system of claim 24 further comprising a patient programmer wirelessly coupled to the implantable stimulator, the patient programmer comprising a user interface;

wherein one of the implantable stimulator and the blood glucose monitor is configured to communicate the blood glucose level to the patient via the user interface.

27. The system of claim 24 wherein the blood glucose monitor comprises a patient interface and wherein the blood glucose monitor is configured to communicate the blood glucose level to the patient via the patient interface.

28. The system of claim 24 wherein the blood glucose monitor is integrated into the implantable stimulator.

29. The system of claim 24 wherein the GES comprises a GES signal comprising a series of pulses having alternating pulse polarities.

30. The system of claim 24 wherein the GES is configured to reduce the blood glucose level of the patient.

31. A system for managing a blood glucose level of a patient comprising:

a food intake sensor;

an implantable stimulator configured to deliver gastric electrical stimulation (GES) to a gastrointestinal tract (GI) of the patient;

wherein the implantable stimulator is configured to generate and deliver the GES when the food intake sensor senses ingestion of food by the patient.